688075 安旭生物
已收盘 10-30 15:00:00
资讯
新帖
简况
安旭生物（688075）披露2026年第三季度报告，10月29日股价下跌2.61%
证券之星 · 10-29 22:43
安旭生物（688075）披露2026年第三季度报告，10月29日股价下跌2.61%
安旭生物(688075.SH)发布前三季度业绩，归母净亏损3043万元
智通财经 · 10-29 21:54
安旭生物(688075.SH)发布前三季度业绩，归母净亏损3043万元
安旭生物获得实用新型专利授权：“钙离子试片”
证券之星 · 10-29 19:46
安旭生物获得实用新型专利授权：“钙离子试片”
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
证券之星 · 10-09
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
股市必读：安旭生物（688075）9月28日披露最新机构调研信息
证券之星 · 09-29
股市必读：安旭生物（688075）9月28日披露最新机构调研信息
安旭生物新注册《安旭生物全自动干式生化分析嵌入式系统V1.0》等2个项目的软件著作权
证券之星 · 09-15
安旭生物新注册《安旭生物全自动干式生化分析嵌入式系统V1.0》等2个项目的软件著作权
每周股票复盘：安旭生物（688075）拟修订高管薪酬制度
证券之星 · 09-13
每周股票复盘：安旭生物（688075）拟修订高管薪酬制度
安旭生物获得实用新型专利授权：“样本检测装置”
证券之星 · 09-12
安旭生物获得实用新型专利授权：“样本检测装置”
股市必读：安旭生物新发布《安旭生物2026年第一次临时股东会会议资料》
证券之星 · 09-10
股市必读：安旭生物新发布《安旭生物2026年第一次临时股东会会议资料》
安旭生物（688075）披露修订董事及高管薪酬管理制度议案，9月9日股价下跌1.76%
证券之星 · 09-09
安旭生物（688075）披露修订董事及高管薪酬管理制度议案，9月9日股价下跌1.76%
每周股票复盘：安旭生物（688075）累计回购股份707,939股
证券之星 · 09-06
每周股票复盘：安旭生物（688075）累计回购股份707,939股
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
证券之星 · 09-03
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
安旭生物（688075）披露股份回购进展公告，9月1日股价上涨2.1%
证券之星 · 09-01
安旭生物（688075）披露股份回购进展公告，9月1日股价上涨2.1%
安旭生物：截至8月31日公司累计回购股份707939股
证券日报 · 09-01
安旭生物：截至8月31日公司累计回购股份707939股
安旭生物(688075)6月30日股东户数0.53万户，较上期减少7.39%
证券之星 · 08-28
安旭生物(688075)6月30日股东户数0.53万户，较上期减少7.39%
股市必读：安旭生物新发布《安旭生物关于召开2026年第一次临时股东会的通知》
证券之星 · 08-28
股市必读：安旭生物新发布《安旭生物关于召开2026年第一次临时股东会的通知》
每周股票复盘：安旭生物（688075）累计回购67.19万股
证券之星 · 08-09
每周股票复盘：安旭生物（688075）累计回购67.19万股
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
证券之星 · 08-05
股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》
安旭生物（688075）披露股份回购进展公告，8月3日股价上涨0.57%
证券之星 · 08-03
安旭生物（688075）披露股份回购进展公告，8月3日股价上涨0.57%
7月17日安旭生物跌5.00%，广发价值核心混合A基金重仓该股
证券之星 · 07-17
7月17日安旭生物跌5.00%，广发价值核心混合A基金重仓该股
加载更多
公司概况
公司名称：
杭州安旭生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-11-18
主营业务：
杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是POCT试剂及仪器。公司为国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心，荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。
发行价格：
78.28
{"stockData":{"symbol":"688075","market":"SH","secType":"STK","nameCN":"安旭生物","latestPrice":27.85,"timestamp":1793343600000,"preClose":28.72,"halted":0,"volume":768783,"delay":0,"changeRate":-0.0303,"floatShares":127000000,"shares":127000000,"eps":-0.1996,"marketStatus":"已收盘","change":-0.87,"latestTime":"10-30 15:00:00","open":28.29,"high":29.11,"low":27.81,"amount":21710600,"amplitude":0.0453,"askPrice":27.85,"askSize":86,"bidPrice":27.81,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-0.1996,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":28.72,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":31.59,"lowLimit":25.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":127082805,"isCdr":false,"pbRate":0.71,"roa":"--","roe":"--","epsLYR":0.55,"committee":-0.6,"marketValue":3539000000,"turnoverRate":0.006,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-02。","afterMarket":{"amount":0,"volume":0,"close":27.85,"buyVolume":0,"sellVolume":0,"time":1793345637746,"indexStatus":"已收盘 10-30 15:30:00","preClose":28.72},"floatMarketCap":3539000000},"requestUrl":"/m/hq/s/688075","defaultTab":"news","newsList":[{"id":"2679560289","title":"安旭生物（688075）披露2026年第三季度报告，10月29日股价下跌2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679560289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679560289?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:43","pubTimestamp":1793285025,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，安旭生物报收于28.72元，较前一交易日下跌2.61%，最新总市值为36.5亿元。近日，杭州安旭生物科技股份有限公司披露《2026年第三季度报告》。报告显示，本报告期营业收入为104,102,629.88元，同比增长8.96%；利润总额为-23,347,380.33元，同比下降950.28%；归属于上市公司股东的净利润为-19,786,418.08元，同比下降491.60%。年初至报告期末，营业收入为292,958,795.06元，同比下降9.94%；利润总额为-40,141,751.15元，同比下降162.49%；归属于上市公司股东的净利润为-30,427,761.17元，同比下降147.28%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900063796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679285397","title":"安旭生物(688075.SH)发布前三季度业绩，归母净亏损3043万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679285397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679285397?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:54","pubTimestamp":1793282063,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安旭生物(688075.SH)披露2026年第三季度报告，前三季度公司实现营收2.93亿元，同比下降9.94%;归母净利润亏损3043万元;扣非净利润亏损8615万元;基本每股收益-0.27元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679409795","title":"安旭生物获得实用新型专利授权：“钙离子试片”","url":"https://stock-news.laohu8.com/highlight/detail?id=2679409795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679409795?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:46","pubTimestamp":1793274389,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示安旭生物新获得一项实用新型专利授权，专利名为“钙离子试片”，专利申请号为CN202522009584.5，授权日为2026年10月16日。今年以来安旭生物新获得专利授权81个，较去年同期增加了68.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900048797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674041970","title":"股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674041970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674041970?lang=zh_cn&edition=full","pubTime":"2026-10-09 01:58","pubTimestamp":1791482290,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，安旭生物报收于30.64元，下跌1.03%，换手率1.09%，成交量1.38万手，成交额4253.76万元。公司公告汇总：截至2026年9月30日，安旭生物累计回购股份791,689股，占总股本0.6230%，已支付金额2,771.85万元。本次回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252307","title":"股市必读：安旭生物（688075）9月28日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671252307?lang=zh_cn&edition=full","pubTime":"2026-09-29 02:21","pubTimestamp":1790619669,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，安旭生物报收于29.91元，上涨0.3%，换手率0.43%，成交量5519.0手，成交额1657.21万元。机构调研要点：截至2026年8月31日，公司累计回购股份707,939股，占总股本0.5571%，支付总额25,344,450.67元。交易信息汇总资金流向9月28日主力资金净流出81.69万元，占总成交额4.93%；游资资金净流出165.1万元，占总成交额9.96%；散户资金净流入246.79万元，占总成交额14.89%。体外诊断试剂以及诊断仪器研发生产项目投资总额5.08亿元，截至6月末投资进度55.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900002154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667698989","title":"安旭生物新注册《安旭生物全自动干式生化分析嵌入式系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2667698989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667698989?lang=zh_cn&edition=full","pubTime":"2026-09-15 02:20","pubTimestamp":1789410024,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安旭生物新注册了2个项目的软件著作权，包括《安旭生物全自动干式生化分析嵌入式系统V1.0》、《KinCare Hub APP0.2.13》等。今年以来安旭生物新注册软件著作权4个，较去年同期减少了60%。通过天眼查大数据分析，杭州安旭生物科技股份有限公司共对外投资了18家企业，参与招投标项目143次；财产线索方面有商标信息76条，专利信息309条，著作权信息59条；此外企业还拥有行政许可117个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500000648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159180","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667857688","title":"每周股票复盘：安旭生物（688075）拟修订高管薪酬制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2667857688","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667857688?lang=zh_cn&edition=full","pubTime":"2026-09-13 04:02","pubTimestamp":1789243339,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，安旭生物报收于28.13元，较上周的29.3元下跌3.99%。本周，安旭生物9月8日盘中最高价报30.23元。安旭生物当前最新总市值35.75亿元，在医疗器械板块市值排名85/129，在两市A股市值排名3933/5218。本周关注点公司公告汇总：安旭生物拟修订高管薪酬制度，强调向关键岗位和一线人才倾斜。公司公告汇总杭州安旭生物科技股份有限公司将召开2026年第一次临时股东会，审议《关于修订<董事和高级管理人员薪酬管理制度>的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666790885","title":"安旭生物获得实用新型专利授权：“样本检测装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666790885","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666790885?lang=zh_cn&edition=full","pubTime":"2026-09-12 03:42","pubTimestamp":1789155779,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示安旭生物新获得一项实用新型专利授权，专利名为“样本检测装置”，专利申请号为CN202521799513.3，授权日为2026年9月11日。本实用新型提供的样本检测装置结构简单，使用者使用时操作更加方便，可提高用户体验和检测效率。今年以来安旭生物新获得专利授权79个，较去年同期增加了107.89%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200003144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532500","title":"股市必读：安旭生物新发布《安旭生物2026年第一次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666532500?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:41","pubTimestamp":1788975671,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，安旭生物报收于29.57元，下跌1.76%，换手率0.35%，成交量4429.0手，成交额1312.67万元。公司公告汇总安旭生物2026年第一次临时股东会会议资料杭州安旭生物科技股份有限公司召开2026年第一次临时股东会，审议《关于修订〈董事和高级管理人员薪酬管理制度〉的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000002110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158116","title":"安旭生物（688075）披露修订董事及高管薪酬管理制度议案，9月9日股价下跌1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158116","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666158116?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:43","pubTimestamp":1788947023,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，安旭生物报收于29.57元，较前一交易日下跌1.76%，最新总市值为37.58亿元。该股当日开盘30.01元，最高30.08元，最低29.42元，成交额达1312.67万元，换手率为0.35%。公司于近日披露《2026年第一次临时股东会会议资料》，拟审议《关于修订<董事和高级管理人员薪酬管理制度>的议案》。制度其余条款不变。现场会议定于2026年9月16日在杭州举行，会议采取现场与网络投票相结合方式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900030365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366357","title":"每周股票复盘：安旭生物（688075）累计回购股份707,939股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366357","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366357?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:09","pubTimestamp":1788635352,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，安旭生物报收于29.3元，较上周的29.52元下跌0.75%。本周，安旭生物9月2日盘中最高价报29.86元。8月31日盘中最低价报28.92元。安旭生物当前最新总市值37.24亿元，在医疗器械板块市值排名86/129，在两市A股市值排名3894/5214。本周关注点公司公告汇总：安旭生物累计回购股份707,939股，占总股本的0.5571%，已支付资金总额2534.45万元。公司公告汇总安旭生物于2026年4月1日启动股份回购，拟回购金额为2,500万元至4,900万元，价格不超过40.2元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664457438","title":"股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664457438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664457438?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:27","pubTimestamp":1788373630,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，安旭生物报收于29.25元，下跌1.52%，换手率0.29%，成交量3656.0手，成交额1072.98万元。当日关注点交易信息汇总：9月2日主力资金净流出212.08万元，占总成交额19.77%。公司公告汇总：截至2026年8月31日，安旭生物累计回购股份707,939股，占总股本0.5571%，已支付资金总额2534.45万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664505578","title":"安旭生物（688075）披露股份回购进展公告，9月1日股价上涨2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664505578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664505578?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:09","pubTimestamp":1788275355,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，安旭生物报收于29.7元，较前一交易日上涨2.1%，最新总市值为37.74亿元。该股当日开盘29.14元，最高29.82元，最低28.96元，成交额达1856.54万元，换手率为0.49%。近日，安旭生物发布《关于股份回购进展公告》。截至2026年8月31日，公司累计回购股份707,939股，占总股本的0.5571%，已支付资金总额2534.45万元，回购价格区间为27.95元/股至38.87元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664399857","title":"安旭生物：截至8月31日公司累计回购股份707939股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664399857","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664399857?lang=zh_cn&edition=full","pubTime":"2026-09-01 21:47","pubTimestamp":1788270420,"startTime":"0","endTime":"0","summary":"9月1日，安旭生物发布公告称，截至2026年8月31日，公司通过股份回购专用证券账户，以集中竞价交易方式累计回购股份707，939股，占公司总股本127，082，805股的比例为0.5571%，回购成交的最高价为38.87元/股，最低价为27.95元/股，支付的资金总额为人民币25，344，450.67元（不含印花税、交易佣金等交易费用）。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-01/doc-iniqitrq4831808.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-01/doc-iniqitrq4831808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662352066","title":"安旭生物(688075)6月30日股东户数0.53万户，较上期减少7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662352066","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662352066?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:40","pubTimestamp":1787910047,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安旭生物披露，截至2026年6月30日公司股东户数为5335.0户，较3月31日减少426.0户，减幅为7.39%。在医疗器械行业个股中，安旭生物股东户数低于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.12万户。从股价来看，2026年3月31日至2026年6月30日，安旭生物区间跌幅为20.06%，在此期间股东户数减少426.0户，减幅为7.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662341450","title":"股市必读：安旭生物新发布《安旭生物关于召开2026年第一次临时股东会的通知》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662341450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662341450?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:16","pubTimestamp":1787876193,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，安旭生物报收于29.48元，下跌0.71%，换手率0.32%，成交量4095.0手，成交额1206.41万元。公司公告汇总安旭生物关于公司2026年度提质增效重回报专项行动方案的半年度评估报告2026年上半年新增授权专利55项，累计授权专利435项；新增国际认证214项，累计达2117项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800015325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658753376","title":"每周股票复盘：安旭生物（688075）累计回购67.19万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658753376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658753376?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:31","pubTimestamp":1786213870,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，安旭生物报收于28.94元，较上周的27.92元上涨3.65%。本周，安旭生物8月7日盘中最高价报28.99元。8月3日盘中最低价报27.79元。安旭生物当前最新总市值36.78亿元，在医疗器械板块市值排名90/129，在两市A股市值排名3831/5205。本次回购用于员工持股计划或股权激励，回购期限为2026年4月1日至2027年3月29日，资金总额预计为2,500万元至4,900万元。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657305565","title":"股市必读：安旭生物新发布《安旭生物关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657305565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657305565?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:37","pubTimestamp":1785868629,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，安旭生物报收于28.32元，上涨0.85%，换手率0.81%，成交量1.02万手，成交额2887.89万元。公司公告汇总：截至2026年7月31日，安旭生物累计回购股份671,939股，占总股本0.5287%，已支付资金总额24,323,862.59元，回购价格区间为30.48元/股至38.87元/股。本次回购用于员工持股计划或股权激励，回购期限为2026年4月1日至2027年3月29日，资金总额预计为2,500万元至4,900万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656776913","title":"安旭生物（688075）披露股份回购进展公告，8月3日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656776913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656776913?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:20","pubTimestamp":1785766824,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，安旭生物报收于28.08元，较前一交易日上涨0.57%，最新总市值为35.68亿元。近日，安旭生物发布《关于股份回购进展公告》。本次回购用于员工持股计划或股权激励，回购期限为2026年4月1日至2027年3月29日，资金总额预计为2,500万元至4,900万元。回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652548405","title":"7月17日安旭生物跌5.00%，广发价值核心混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652548405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652548405?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:20","pubTimestamp":1784276449,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日安旭生物跌5.00%，收盘报29.06元，换手率0.78%，成交量9931.0手，成交额2944.58万元。重仓安旭生物的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为广发基金的广发价值核心混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700029675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793389343983,"stockEarnings":[{"period":"1week","weight":-0.0453},{"period":"1month","weight":-0.1005},{"period":"3month","weight":-0.0025},{"period":"6month","weight":-0.2356},{"period":"1year","weight":-0.2624},{"period":"ytd","weight":-0.2603}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安旭生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6353人(较上一季度增加19.08%)","perCapita":"20003股","listingDate":"2021-11-18","address":"浙江省杭州市拱墅区莫干山路1418-50号4幢3层(上城科技工业基地)","registeredCapital":"12708万元","survey":" 杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是POCT试剂及仪器。公司为国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心，荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。","listedPrice":78.28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安旭生物,688075,安旭生物股票,安旭生物股票老虎,安旭生物股票老虎国际,安旭生物行情,安旭生物股票行情,安旭生物股价,安旭生物股市,安旭生物股票价格,安旭生物股票交易,安旭生物股票购买,安旭生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}